LATS1 Polyclonal antibody 17049-1-AP proteintech

$149.00
In stock
SKU
17049-1-AP
Catalog No.SizePrice (USD)
17049-1-AP-20UL20 μL$149.00
17049-1-AP-150UL150 μL$449.00
Catalog Number17049-1-AP
SynonymsEC:2.7.11.1, h-warts, LATS 1, Serine/threonine-protein kinase LATS1, WARTS
HostRabbit
Reactivityhuman, mouse and More (2)
Reactivityhuman, mouse, pig, sheep
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, RIP, ELISA
ApplicationsWB, IHC, IF/ICC, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inHepG2 cells, K-562 cells, SH-SY5Y cells, HT-29 cells, A549 cells, C2C12 cells
Tested Applications — Positive IHC detected inhuman breast cancer tissue, human testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF/ICC detected inHeLa cells
Recommended Dilutions — Western Blot (WB)WB : 1:500-1:2000
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:50-1:500
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
Positive WB detected inHepG2 cells, K-562 cells, SH-SY5Y cells, HT-29 cells, A549 cells, C2C12 cells
Positive IHC detected inhuman breast cancer tissue, human testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHeLa cells
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
Tested Reactivityhuman, mouse
Cited Reactivityhuman, mouse, pig, sheep
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag10709 Product name: Recombinant human LATS1 protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 1-135 aa of BC015665 Sequence: MKRSEKPEGYRQMRPKTFPASNYTVSSRQMLQEIRESLRNLSKPSDAAKAEHNMSKMSTEDPRQVRNPPKFGTHHKALQEIRNSLLPFANETNSSRSTSEVNPQMLQDLQAAGFDEEDHLSVACSPISLTKPFLI Predict reactive species
Full NameLATS, large tumor suppressor, homolog 1 (Drosophila)
Calculated Molecular Weight15 kDa, 127 kDa
Observed Molecular Weight140-150 kDa, 120 kDa
GenBank Accession NumberBC015665
Gene SymbolLATS1
Gene ID (NCBI)9113
RRIDAB_2281011
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDQ6PJG3
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for LATS1 antibody 17049-1-APDownload protocol
IHC protocol for LATS1 antibody 17049-1-APDownload protocol
WB protocol for LATS1 antibody 17049-1-APDownload protocol
humanWB Theranostics CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways. Authors - Lixia Chen View Article
mouseWB Oncogene Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma. Authors - Yongyun Li View Article
Citations94
DilutionsWB : 1:500-1:2000 IHC : 1:50-1:500 IF/ICC : 1:50-1:500
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

LATS1(Large tumor suppressor homolog 1) is also named as WARTS and belongs to the AGC Ser/Thr protein kinase family. The gene encodes a highly conserved (from fly to human) protein kinase that plays a crucial role in the prevention of tumor formation by controlling the progression of mitosis. The expression of both long(170 kDa) and short lats1 isoforms(120 kDa) in vertebrate retinal cells raises the possibility that these lats1 proteins may act as negative key regulators of the cell cycle each of them performing a unique role (PMID:15777619). In mammalian cells, LATS1 was phosphorylated in a cell cycle-dependent manner and complexed with CDC2 in early mitosis (PMID:9988268). LATS1 also can be detected as 120 kDa and 140-150 kDa, and play a key role in the regulation of Hippo pathway (PMID: 27940445). Protocols Product Specific Protocols IF protocol for LATS1 antibody 17049-1-AP Download protocol IHC protocol for LATS1 antibody 17049-1-AP Download protocol WB protocol for LATS1 antibody 17049-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling.
    Journal: Cell Res | Authors: Rui-Hua Li | Species: human | Application: IF
  2. Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis.
    Journal: Nat Commun | Authors: Shujie Chen | Species: human | Application: WB
  3. MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression
    Journal: EMBO J | Authors: Yan Sun | Species: human | Application: WB
  4. CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways.
    Journal: Theranostics | Authors: Lixia Chen | Species: human | Application: WB
  5. KIBRA upregulation increases susceptibility to glomerular injury and correlates with kidney function decline
    Journal: JCI Insight | Authors: Kristin Meliambro | Species: mouse | Application: IHC
  6. Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma.
    Journal: Oncogene | Authors: Yongyun Li | Species: mouse | Application: WB
  7. Protein Coronation-Induced Cancer Staging-Dependent Multilevel Cytotoxicity: An All-Humanized Study in Blood Vessel Organoids
    Journal: ACS Nano | Authors: Chan Wang | Species: human | Application: IF
  8. Matrix stiffness drives squamous cell carcinoma progression via a Piezo1-mediated mechanotransduction feedback loop.
    Journal: J Adv Res | Authors: Zixi Jiang | Species: mouse,human | Application: WB
  9. CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways.
    Journal: Theranostics | Authors: Lixia Chen | Species: human | Application: WB
  10. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
    Journal: J Exp Clin Cancer Res | Authors: Xiaodong Zhang | Species: human | Application: WB
  11. TEAD1 Enhances Exosome Secretion and Promotes Exosome-Mediated Tissue Regeneration.
    Journal: Adv Sci (Weinh) | Authors: Yan Pu | Species: mouse,human | Application: WB
  12. The E3 Ligase RNF115 Aggravates Pathological Cardiac Hypertrophy via Ubiquitin-Mediated Degradation of SPTBN1.
    Journal: Adv Sci (Weinh) | Authors: Yan Zu
  13. Cyclin K condensates bridge CDK12 to phosphorylate and drive oncogenic YAP activation in hepatocellular carcinoma.
    Journal: Sci Adv | Authors: Yang Sun
  14. The EZH2 selective inhibitor ZLD1039 attenuates UUO-induced renal fibrosis by suppressing YAP activation
    Journal: Mol Biomed | Authors: Qingling Xia | Species: human | Application: WB,IHC
  15. Alginate oligosaccharide attenuates α2,6-sialylation modification to inhibit prostate cancer cell growth via the Hippo/YAP pathway.
    Journal: Cell Death Dis | Authors: Yang Han | Species: human | Application: IHC
  16. PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling
    Journal: Cell Death Dis | Authors: Hualin Chen | Species: human | Application: WB
  17. The circadian gene ARNTL2 promotes nasopharyngeal carcinoma invasiveness and metastasis through suppressing AMOTL2-LATS-YAP pathway
    Journal: Cell Death Dis | Authors: Wenqing Zou | Species: human | Application: IF
  18. Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48
    Journal: J Immunother Cancer | Authors: Jiatong Xiao | Application: WB
  19. Mechanical cues rewire lipid metabolism and support chemoresistance in epithelial ovarian cancer cell lines OVCAR3 and SKOV3
    Journal: Cell Commun Signal | Authors: Martina Karasová
  20. Mechanism of action of HuPoSan on EMs rats as revealed by multi-omics combined with network pharmacology.
    Journal: Phytomedicine | Authors: Chaoyue Huo | Application: WB
  21. Synergistic Intervention of Piezo1 Activation and Fibrous Tissue Remodeling to Ease Side Effects of Intralesional Therapy for Keloids.
    Journal: Adv Healthc Mater | Authors: Zixi Jiang | Species: human | Application: IF
  22. KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury.
    Journal: Acta Pharmacol Sin | Authors: Dan Xu | Species: mouse | Application: WB,IHC
  23. Modulation of SRC by SNTB1 activates the Hippo-YAP pathway during colon adenocarcinoma metastasis
    Journal: J Transl Med | Authors: Zhengyan Chang
  24. Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma.
    Journal: Oncogene | Authors: Yongyun Li | Species: mouse | Application: WB
  25. GADD45B promotes apoptosis in intestinal ischemia/reperfusion through DNA demethylation of MST1/Hippo.
    Journal: Chin Med J (Engl) | Authors: Fengyuan Yang | Species: mouse,human | Application: WB
  26. TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ.
    Journal: Oncogene | Authors: Sha Zhou
  27. HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer
    Journal: Oncogene | Authors: Tongyu Tong | Application: WB
  28. Laminin β1 stimulates the Hippo-YAP1 pathway to advance the progression and lenvatinib resistance in hepatocellular carcinoma.
    Journal: Int J Biol Macromol | Authors: Zhiliang Cai | Species: human | Application: WB
  29. MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression
    Journal: EMBO J | Authors: Yan Sun | Species: human | Application: WB
  30. Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of AGTR1+ CAFs in intrahepatic cholangiocarcinoma
    Journal: Clin Transl Med | Authors: Jian-Hui Li | Species: human | Application: WB
  31. A LATS2 and ALKBH5 positive feedback loop supports their oncogenic roles
    Journal: Cell Rep | Authors: Lei Cao | Species: human | Application: WB
  32. Glutamine synthetase modulates YAP activation by stabilizing LATS under glutamine homeostasis.
    Journal: Cell Rep | Authors: Siyi Li | Species: mouse,human | Application: IHC
  33. METTL3 regulates cartilage development and homeostasis by affecting Lats1 mRNA stability in an m6A-YTHDF2-dependent manner
    Journal: Cell Rep | Authors: Rui Sheng | Species: mouse | Application: WB,RIP
  34. Inhibition of Hippo Signaling Through Ablation of Lats1 and Lats2 Protects Against Cognitive Decline in 5xFAD Mice via Increasing Neuronal Resilience Against Ferroptosis
    Journal: Aging Cell | Authors: Robert C Evans
  35. Microcystin-LR facilitates pubertal bone retardation by interfering with glutamine metabolism to accelerate stem cell senescence through Hippo/GLS pathway
    Journal: Environ Pollut | Authors: Chun Pan | Application: WB
  36. STUPPIT is a proximity labeling tool for labeling intermediary proteins that bridge two non-interacting proteins.
    Journal: PLoS Biol | Authors: Lin Xie | Species: human | Application: WB
  37. Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling.
    Journal: JCI Insight | Authors: Zhiguo Chen | Species: human | Application: WB,IHC
  38. KIBRA upregulation increases susceptibility to glomerular injury and correlates with kidney function decline
    Journal: JCI Insight | Authors: Kristin Meliambro | Species: mouse | Application: IHC
  39. The Hippo signaling pathway regulates corneal endothelial regeneration.
    Journal: Ocul Surf | Authors: Jingbin Zhuang
  40. Elucidating the correlation between polychlorinated dibenzo-p-dioxins and prostate cancer progression: Insights from gene expression and molecular docking
    Journal: Ecotoxicol Environ Saf | Authors: Fei Lin | Species: human | Application: WB
  41. Pharmacological inhibition of the MST2/Hippo signaling pathway mitigates Toxoplasma gondii-induced apoptosis and immunopathology in macrophage and mice liver.
    Journal: Biochem Pharmacol | Authors: Kangzhi Xu | Species: mouse | Application: WB
  42. Tumor-associated macrophage-derived exosomal miR21-5p promotes tumor angiogenesis by regulating YAP1/HIF-1α axis in head and neck squamous cell carcinoma
    Journal: Cell Mol Life Sci | Authors: Quan Yan | Species: human | Application: WB
  43. YAP inactivated by NF-κB p65, can protect against colonic epithelial cell pyroptosis in ulcerative colitis via transcriptionally regulating NLRP3.
    Journal: Life Sci | Authors: Mengmeng Xu | Species: mouse,human | Application: WB
  44. A derivant of ginsenoside CK and its inhibitory effect on hepatocellular carcinoma.
    Journal: Life Sci | Authors: Jingjing Zhang | Species: human | Application: WB
  45. Oleanolic acid, a small-molecule natural product, inhibits ECM degeneration in osteoarthritis by regulating the Hippo/YAP and Wnt/β-catenin pathways
    Journal: Food Funct | Authors: Tianwen Ma | Application: WB
  46. Leonurine Attenuates CCl4-Induced Hepatic Fibrosis in Mice via the Hippo-YAP Pathway
    Journal: Drug Des Devel Ther | Authors: Pengru Wang | Species: human | Application: WB
  47. Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP.
    Journal: Cells | Authors: Minjing Li | Species: human | Application: WB
  48. Hippo Pathway Dysregulation in Thymic Epithelial Tumors (TETs): Associations with Clinicopathological Features and Patients' Prognosis
    Journal: Int J Mol Sci | Authors: Lisa Elm | Application: IHC
  49. Hypoxia-induced tumor cell-intrinsic PLAU activation drives immunotherapy resistance in collagenic lung adenocarcinoma
    Journal: Int Immunopharmacol | Authors: Li Wan | Species: human | Application: WB
  50. Ischemia-inhibited ferric chelate reductase 1 improves ferroptosis-mediated intestinal ischemia injury via Hippo signaling
    Journal: Int Immunopharmacol | Authors: Pengzhen Liang | Species: mouse | Application: WB
  51. Neuregulin-1 reduces Doxorubicin-induced cardiotoxicity by upregulating YAP to inhibit senescence
    Journal: Int Immunopharmacol | Authors: Henghe Shi | Application: WB
  52. ACTL6A accelerates the progression of NSCLC through hippo/YAP signaling axis and TAMs-mediated immune regulation.
    Journal: Int Immunopharmacol | Authors: Luyun Cui | Species: mouse,human | Application: WB
  53. RNF19A facilitates gastric cancer progression by regulating the Hippo/YAP axis.
    Journal: Int Immunopharmacol | Authors: Yu Cheng | Species: human | Application: WB
  54. YAP Regulates the Nrf2 Signaling Axis to Attenuate Oxidative Stress and Neuroinflammation in Retinal Ganglion Cell Degeneration.
    Journal: Invest Ophthalmol Vis Sci | Authors: Shirui Zhou | Species: mouse | Application: WB
  55. Tetramethylpyrazine Ameliorates Peritoneal Angiogenesis by Regulating VEGF/Hippo/YAP Signaling.
    Journal: Front Pharmacol | Authors: Xiaolin Zhu | Species: human | Application: WB
  56. Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway.
    Journal: Front Pharmacol | Authors: Wanyun Zuo | Application: WB
  57. Targeting Mechanosensitive Piezo1 Alleviated Renal Fibrosis Through p38MAPK-YAP Pathway.
    Journal: Front Cell Dev Biol | Authors: Yuanyuan Fu | Species: mouse | Application: WB
  58. FTO attenuates the cytotoxicity of cisplatin in KGN granulosa cell-like tumour cells by regulating the Hippo/YAP1 signalling pathway
    Journal: J Ovarian Res | Authors: Rongli Wang | Species: human | Application: WB
  59. Celastrol induces cardiotoxicity by directly targeting AMOTL2 and inhibiting YAP1/PGC-1α/TFAM-dependent mitochondrial biogenesis.
    Journal: Chem Biol Interact | Authors: Huiying Shang | Species: human | Application: WB
  60. N-Acetyl-l-tryptophan inhibits CCl4-induced hepatic fibrogenesis via regulating TGF-β1/SMAD and Hippo/YAP1 signal.
    Journal: Bioorg Chem | Authors: Tingting Ma | Species: mouse | Application: WB
  61. N-Acetyl-l-tryptophan inhibits CCl4-induced hepatic fibrogenesis via regulating TGF-β1/SMAD and Hippo/YAP1 signal.
    Journal: Bioorg Chem | Authors: Tingting Ma | Species: mouse | Application: WB
  62. Tadalafil enhances the therapeutic efficacy of BET inhibitors in hepatocellular carcinoma through activating Hippo pathway.
    Journal: Biochim Biophys Acta Mol Basis Dis | Authors: Deqiang Kong | Species: human | Application: WB
  63. Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells.
    Journal: Mol Med Rep | Authors: Cheng Wang | Species: human | Application: WB,IHC
  64. The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.
    Journal: Cancer Sci | Authors: Jiayi Li | Species: human | Application: IHC
  65. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer.
    Journal: Cancers (Basel) | Authors: Bowen Zhu | Species: human | Application: WB
  66. Hippo/YAP1 promotes osteoporotic mice bone defect repair via the activating of Wnt signaling pathway
    Journal: Cell Signal | Authors: Kehan Li | Application: WB
  67. Epigenetic silencing of JAM3 promotes laryngeal squamous cell carcinoma development by inhibiting the Hippo pathway
    Journal: Oncol Rep | Authors: Yue Jia | Species: human | Application: WB
  68. Hippo/YAP1 promotes osteoporotic mice bone defect repair via the activating of Wnt signaling pathway
    Journal: Cell Signal | Authors: Kehan Li | Application: WB
  69. The serotonin receptor 2b (5-HT(2B)) modulates heart remodeling following myocardial infarction via regulation of Hippo pathway.
    Journal: iScience | Authors: Ryan Potter | Application: WB
  70. Toxoplasma gondii induces MST2 phosphorylation mediating the activation of hippo signaling pathway to promote apoptosis and lung tissue damage
    Journal: iScience | Authors: Kangzhi Xu | Species: pig,mouse | Application: WB
  71. Folic Acid Alleviates High Glucose and Fat-Induced Pyroptosis via Inhibition of the Hippo Signal Pathway on H9C2 Cells.
    Journal: Front Mol Biosci | Authors: Lei Hong | Species: mouse | Application: WB
  72. ACSS2 enables melanoma cell survival and tumor metastasis by negatively regulating the Hippo pathway
    Journal: Front Mol Biosci | Authors: Baolu Zhang | Species: human | Application: WB
  73. The TRIP6/LATS1 complex constitutes the tension sensor of α-catenin/vinculin at both bicellular and tricellular junctions.
    Journal: Eur J Cell Biol | Authors: Lin Xie | Species: human | Application: IF
  74. LINC00673-V4 Promotes Colorectal Cancer Cell Proliferation by Interacting With FUS and Restoring the Expression of Hippo-YAP Target Genes.
    Journal: Front Biosci (Landmark Ed) | Authors: Wei Lu
  75. Heat-shock protein B1 upholds the cytoplasm reduced state to inhibit activation of the Hippo pathway in H9c2 cells.
    Journal: J Cell Physiol | Authors: Xiehong Liu | Application: WB
  76. Centromere protein K enhances the activation of YAP1/TAZ signal cascade to drive the progression of clear cell renal cell carcinoma
    Journal: Toxicol Appl Pharmacol | Authors: Ning Nan | Species: human | Application: WB
  77. Caulerpin suppresses tumor-associated angiogenesis and tumor growth via Hippo signaling in cervical cancer.
    Journal: Toxicol Appl Pharmacol | Authors: Guang Yang | Species: human | Application: WB
  78. FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis.
    Journal: Front Oncol | Authors: Yi-Wen Zheng | Species: human | Application: WB
  79. FGF2 promotes the proliferation of injured granulosa cells in premature ovarian failure via Hippo-YAP signaling pathway
    Journal: Mol Cell Endocrinol | Authors: Feiyan Cheng | Species: human | Application: WB
  80. NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression.
    Journal: Front Oncol | Authors: Lijun Wang | Species: human | Application: WB
  81. LATS1 exerts tumor suppressor functions via targeting Gli1 in colorectal cancer.
    Journal: J Cancer | Authors: Zhengchao Shen | Species: human | Application: IHC
  82. Exercise therapy-associated changes in Periostin (POSTN) osteoarthritis are linked to Hippo-YAP signaling.
    Journal: Mol Biol Rep | Authors: Dandan Hao
  83. Upstream transcription factor 1 suppresses laryngeal squamous cell carcinoma progression through transcriptional activation of junctional adhesion molecule 3
    Journal: IUBMB Life | Authors: Yue Jia | Species: human | Application: WB,IHC
  84. Targeting mechanics-induced trabecular meshwork dysfunction through YAP-TGFβ Ameliorates high myopia-induced ocular hypertension
    Journal: Exp Eye Res | Authors: Qianwen Bu | Species: human | Application: WB
  85. Expression of Hippo signaling pathway components in Hu sheep male reproductive tract and spermatozoa.
    Journal: Theriogenology | Authors: Guo-Min Zhang | Species: sheep | Application: WB,IHC,IF
  86. CXCR7 promoted proliferation, migration and invasion in HCC Cells by inactivating Hippo-YAP signaling
    Journal: Discov Oncol | Authors: Genwang Wang | Species: human | Application: WB
  87. miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway.
    Journal: Discov Oncol | Authors: Wei Huang | Species: human | Application: WB
  88. LATS1/YAP1 Axis Controls Bone Regeneration on Distraction Osteogenesis by Activating Wnt/β-Catenin
    Journal: Tissue Eng Part A | Authors: Kehan Li | Application: WB,IHC
  89. SiO(2) dust induces the transformation of lung fibroblasts to myofibroblasts by activating the S1P-RhoA-YAP signaling pathway.
    Journal: Toxicol In Vitro | Authors: Hualing Zhang | Species: human | Application: WB
  90. Metformin Exhibits an Attractive Antineoplastic Effect on Human Endometrial Cancer by Regulating the Hippo Signaling Pathway
    Journal: J Oncol | Authors: Meng Wang | Species: human | Application: WB
  91. IGF-1R/YAP signaling pathway is involved in collagen V-induced insulin biosynthesis and secretion in rat islet INS-1 cells.
    Journal: Connect Tissue Res | Authors: Yingying Zhu | Application: WB
  92. Effect of antenatal tetramethylpyrazine on lung development and YAP expression in rat model of experimental congenital diaphragmatic hernia.
    Journal: Int J Clin Exp Pathol | Authors: Junzuo Liao | Application: WB
  93. Transforming growth factor-beta1 suppresses hepatocellular carcinoma proliferation via activation of Hippo signaling.
    Journal: Oncotarget | Authors: Xiaodong Zhang | Species: human | Application: WB
  94. Endometrial stem cell-derived exosomes repair cisplatin-induced premature ovarian failure via Hippo signaling pathway
    Journal: Heliyon | Authors: Lijun Wang | Species: human | Application: WB

Reviews

Write Your Own Review
You're reviewing:LATS1 Polyclonal antibody 17049-1-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.